Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1201
4.700
 Why?
Early Detection of Cancer
6
2020
163
2.360
 Why?
Ultrasonography, Mammary
8
2020
61
2.030
 Why?
Mass Screening
3
2020
344
1.510
 Why?
Colorectal Neoplasms
4
2018
260
1.500
 Why?
Healthcare Disparities
3
2017
281
1.080
 Why?
Mastectomy
13
2019
142
1.070
 Why?
Mastectomy, Segmental
7
2018
93
1.050
 Why?
Sentinel Lymph Node Biopsy
10
2015
118
1.000
 Why?
Community Health Planning
3
2018
26
0.980
 Why?
Ultrasonography, Interventional
5
2020
137
0.840
 Why?
Biopsy, Needle
10
2015
178
0.830
 Why?
Focus Groups
1
2024
194
0.830
 Why?
Neoplasm Staging
14
2024
746
0.810
 Why?
Biopsy, Large-Core Needle
3
2020
33
0.810
 Why?
Female
55
2024
27081
0.770
 Why?
Genetic Counseling
1
2022
41
0.760
 Why?
Neoplasms
5
2015
1251
0.750
 Why?
Lymph Nodes
7
2015
257
0.750
 Why?
Health Status Disparities
3
2015
202
0.740
 Why?
Patient Education as Topic
1
2024
320
0.720
 Why?
Image Interpretation, Computer-Assisted
1
2020
105
0.680
 Why?
Middle Aged
40
2024
12611
0.650
 Why?
Image-Guided Biopsy
2
2020
33
0.650
 Why?
Hematoma
4
2018
64
0.640
 Why?
Surgery, Computer-Assisted
2
2018
55
0.630
 Why?
Polymorphism, Single Nucleotide
2
2018
475
0.620
 Why?
Humans
60
2024
50503
0.610
 Why?
Mandatory Programs
1
2018
21
0.590
 Why?
Adiposity
1
2019
137
0.580
 Why?
Faculty, Medical
3
2021
92
0.570
 Why?
Health Care Costs
1
2018
167
0.560
 Why?
Aged
31
2024
9741
0.550
 Why?
Adult
32
2024
13577
0.550
 Why?
Insurance Coverage
1
2018
110
0.540
 Why?
Disease Management
1
2018
178
0.530
 Why?
Diagnostic Imaging
1
2018
180
0.520
 Why?
Minority Groups
3
2015
130
0.510
 Why?
Arkansas
9
2018
1985
0.500
 Why?
Retrospective Studies
19
2022
6263
0.470
 Why?
Physicians
1
2018
232
0.460
 Why?
Health Planning Councils
1
2014
6
0.450
 Why?
Community-Based Participatory Research
2
2015
198
0.430
 Why?
Health Policy
1
2014
146
0.410
 Why?
Rural Population
1
2017
554
0.410
 Why?
Follow-Up Studies
11
2018
2242
0.400
 Why?
Aged, 80 and over
14
2018
3226
0.390
 Why?
Qualitative Research
3
2024
349
0.390
 Why?
Community Networks
2
2015
49
0.380
 Why?
Community-Institutional Relations
1
2011
46
0.380
 Why?
Primary Health Care
2
2024
366
0.380
 Why?
Carcinoma, Lobular
2
2015
33
0.370
 Why?
Carcinoma, Ductal, Breast
4
2015
91
0.370
 Why?
Population Surveillance
1
2012
164
0.360
 Why?
Physicians, Women
2
2021
22
0.350
 Why?
Neoplasm Recurrence, Local
6
2014
629
0.340
 Why?
Women's Health
1
2010
85
0.330
 Why?
Health Education
2
2008
153
0.330
 Why?
Needs Assessment
2
2024
136
0.320
 Why?
Medical Oncology
1
2010
98
0.320
 Why?
Breast Diseases
4
2018
25
0.310
 Why?
Nipples
5
2013
33
0.290
 Why?
Schools, Medical
2
2020
70
0.290
 Why?
Health Knowledge, Attitudes, Practice
1
2012
491
0.290
 Why?
Axilla
6
2015
91
0.290
 Why?
Socioeconomic Factors
3
2018
591
0.280
 Why?
Morbidity
2
2018
130
0.280
 Why?
Physician-Patient Relations
2
2012
142
0.270
 Why?
Health Services Accessibility
1
2011
424
0.270
 Why?
Catheter Ablation
4
2014
120
0.260
 Why?
Mammaplasty
3
2013
44
0.250
 Why?
Prognosis
9
2024
1978
0.250
 Why?
Mentors
1
2006
55
0.250
 Why?
Lymphatic Metastasis
7
2015
222
0.250
 Why?
Survivors
2
2024
128
0.240
 Why?
Occult Blood
2
2017
22
0.240
 Why?
United States
7
2022
4955
0.230
 Why?
Young Adult
5
2024
4102
0.230
 Why?
Magnetic Resonance Imaging
5
2014
1548
0.220
 Why?
Referral and Consultation
2
2024
288
0.210
 Why?
Education, Medical, Graduate
2
2022
217
0.210
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.200
 Why?
Male
13
2022
25907
0.200
 Why?
Empathy
1
2002
48
0.190
 Why?
Problem-Based Learning
1
2002
49
0.190
 Why?
Atrial Fibrillation
1
2024
188
0.190
 Why?
Emotions
1
2023
168
0.190
 Why?
Breast
2
2020
85
0.180
 Why?
Genetic Testing
1
2022
120
0.180
 Why?
Democratic Republic of the Congo
1
2020
4
0.180
 Why?
Dermatologic Surgical Procedures
3
2013
34
0.180
 Why?
Counseling
1
2022
134
0.180
 Why?
Combined Modality Therapy
4
2018
641
0.180
 Why?
Feasibility Studies
2
2020
390
0.180
 Why?
Biopsy, Fine-Needle
1
2020
108
0.170
 Why?
Research Support as Topic
1
2020
45
0.170
 Why?
Students, Medical
1
2002
162
0.170
 Why?
General Surgery
1
2021
108
0.160
 Why?
Surgical Flaps
2
2019
114
0.160
 Why?
Obesity
1
2008
1121
0.160
 Why?
Prospective Studies
10
2024
2378
0.160
 Why?
Incidence
2
2024
1032
0.160
 Why?
Patient Satisfaction
2
2019
278
0.160
 Why?
Radiopharmaceuticals
4
2008
204
0.150
 Why?
Adipose Tissue
1
2019
192
0.140
 Why?
Logistic Models
2
2018
900
0.140
 Why?
Diagnosis, Differential
1
2020
1033
0.140
 Why?
Rural Health
1
2017
89
0.140
 Why?
Lymphatic Vessels
2
2008
53
0.140
 Why?
Odds Ratio
1
2018
551
0.140
 Why?
Internship and Residency
1
2022
447
0.130
 Why?
Zambia
3
2024
3
0.130
 Why?
Mammography
1
2016
101
0.130
 Why?
Rural Health Services
1
2018
169
0.130
 Why?
Genetic Predisposition to Disease
1
2018
511
0.120
 Why?
Cytodiagnosis
2
2013
41
0.120
 Why?
Risk Assessment
2
2018
1270
0.120
 Why?
Case-Control Studies
1
2018
1156
0.120
 Why?
Cross-Sectional Studies
3
2021
1610
0.120
 Why?
National Cancer Institute (U.S.)
1
2015
30
0.120
 Why?
Survival Rate
1
2017
909
0.120
 Why?
Uterine Cervical Neoplasms
1
2017
276
0.120
 Why?
Algorithms
1
2018
625
0.110
 Why?
Career Mobility
2
2021
28
0.110
 Why?
Patient Care Planning
1
2013
66
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
45
0.110
 Why?
Education, Medical
2
2006
112
0.100
 Why?
Monitoring, Intraoperative
3
2014
54
0.100
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
17
0.100
 Why?
Health Services
1
2012
65
0.090
 Why?
Colonoscopy
1
2012
100
0.090
 Why?
Lymph Node Excision
4
2008
131
0.090
 Why?
Reproducibility of Results
1
2015
1197
0.090
 Why?
Feces
1
2012
134
0.090
 Why?
Treatment Outcome
9
2017
5283
0.090
 Why?
Receptors, Estrogen
2
2015
132
0.090
 Why?
Pancreatic Neoplasms
1
2013
206
0.090
 Why?
Lymphedema
2
2008
46
0.090
 Why?
Fructose
1
2010
22
0.090
 Why?
Clinical Competence
1
2013
398
0.090
 Why?
Patient Compliance
1
2012
233
0.090
 Why?
Carbon
1
2010
55
0.090
 Why?
Registries
1
2013
563
0.090
 Why?
History, 21st Century
1
2010
56
0.080
 Why?
Risk Factors
3
2024
3724
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1000
0.080
 Why?
Carcinoma in Situ
2
2006
73
0.080
 Why?
Patient Acceptance of Health Care
1
2012
342
0.070
 Why?
Delivery of Health Care
1
2011
303
0.070
 Why?
Models, Theoretical
2
2006
170
0.070
 Why?
Prochlorperazine
1
2006
6
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.070
 Why?
Sensitivity and Specificity
3
2004
859
0.070
 Why?
Antiemetics
1
2006
31
0.060
 Why?
Education, Medical, Continuing
1
2006
71
0.060
 Why?
Receptor, erbB-2
1
2006
75
0.060
 Why?
Body Weights and Measures
1
2005
17
0.060
 Why?
Biopsy
2
2004
588
0.060
 Why?
Predictive Value of Tests
2
2013
930
0.060
 Why?
Intraoperative Care
2
2003
52
0.060
 Why?
Gadolinium
1
2005
46
0.060
 Why?
Interprofessional Relations
1
2006
83
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Neoadjuvant Therapy
2
2017
120
0.060
 Why?
Botulinum Toxins, Type A
1
2004
13
0.060
 Why?
Imaging, Three-Dimensional
1
2005
150
0.060
 Why?
Contrast Media
1
2005
192
0.060
 Why?
Life Expectancy
1
2024
33
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Anthracyclines
1
2024
29
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
42
0.050
 Why?
Neoplasm Grading
2
2014
122
0.050
 Why?
Pain, Postoperative
1
2004
163
0.050
 Why?
Preoperative Care
3
2014
169
0.050
 Why?
Surgical Instruments
1
2002
27
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Life Change Events
1
2002
36
0.050
 Why?
Confidence Intervals
1
2002
154
0.050
 Why?
Career Choice
1
2002
112
0.050
 Why?
Program Development
1
2002
162
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
243
0.050
 Why?
Leadership
1
2021
100
0.040
 Why?
Neoplasm Invasiveness
2
2010
269
0.040
 Why?
Vacuum
2
2011
13
0.040
 Why?
Curriculum
1
2002
400
0.040
 Why?
Stereotaxic Techniques
2
2010
38
0.040
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
45
0.030
 Why?
Gene Frequency
1
2017
97
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Adolescent
3
2013
6443
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
182
0.030
 Why?
Guidelines as Topic
1
2016
109
0.030
 Why?
Regression Analysis
1
2017
382
0.030
 Why?
Neovascularization, Pathologic
1
2017
155
0.030
 Why?
Coloring Agents
2
2007
66
0.030
 Why?
Radionuclide Imaging
2
2007
116
0.030
 Why?
Educational Status
1
2016
230
0.030
 Why?
Genotype
1
2017
533
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
64
0.030
 Why?
Cohort Studies
2
2011
1452
0.030
 Why?
Cyclophosphamide
1
2015
168
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Ultrasonography, Doppler
1
2014
41
0.030
 Why?
Carcinoma
1
2015
137
0.030
 Why?
Angiogenesis Inhibitors
1
2015
183
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
226
0.030
 Why?
Disease-Free Survival
1
2014
444
0.030
 Why?
Kaplan-Meier Estimate
1
2014
464
0.030
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
12
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
102
0.020
 Why?
Substrate Specificity
1
2010
192
0.020
 Why?
Actins
1
2010
114
0.020
 Why?
Tumor Cells, Cultured
1
2010
457
0.020
 Why?
Cell Movement
1
2010
247
0.020
 Why?
Breast Neoplasms, Male
1
2009
5
0.020
 Why?
Pilot Projects
1
2011
698
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
739
0.020
 Why?
Cost-Benefit Analysis
1
2008
266
0.020
 Why?
Positron-Emission Tomography
1
2008
292
0.020
 Why?
Administration, Rectal
1
2006
10
0.020
 Why?
Cell Line, Tumor
1
2010
1398
0.020
 Why?
Primary Prevention
1
2006
44
0.020
 Why?
Probability
1
2006
164
0.020
 Why?
Drug Administration Schedule
1
2006
370
0.020
 Why?
Administration, Oral
1
2006
434
0.010
 Why?
Carcinoma, Ductal
1
2004
7
0.010
 Why?
Tissue Expansion
1
2004
4
0.010
 Why?
Pectoralis Muscles
1
2004
5
0.010
 Why?
Spasm
1
2004
9
0.010
 Why?
Rectus Abdominis
1
2004
10
0.010
 Why?
Multivariate Analysis
1
2006
583
0.010
 Why?
Laser Coagulation
1
2004
26
0.010
 Why?
Cryosurgery
1
2004
36
0.010
 Why?
Sampling Studies
1
2004
36
0.010
 Why?
Statistics, Nonparametric
1
2004
192
0.010
 Why?
Chi-Square Distribution
1
2004
277
0.010
 Why?
Injections
1
2003
57
0.010
 Why?
Pain Measurement
1
2004
270
0.010
 Why?
Ultrasonography
1
2004
435
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1372
0.010
 Why?
Length of Stay
1
2004
629
0.010
 Why?
Reoperation
1
2002
460
0.010
 Why?
Analgesics, Opioid
1
2004
575
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department